Rebecca Boyce

Cost-effectiveness of targeted screening for the identification of patients with atrial fibrillation: evaluation of a machine learning risk prediction algorithm

Nathan R. Hill, Belinda Sandler, Ruth Mokgokong et al. · Journal of Medical Economics · 2019 · 37 citations · Full text

Pharmacy, Cardiology, Pharmacoeconomics +17

The cost‐effectiveness of dapagliflozin in treating high‐risk patients with type 2 diabetes mellitus: An economic evaluation using data from the DECLARE‐TIMI 58 trial

Phil McEwan, Angharad R. Morgan, Rebecca Boyce et al. · Diabetes Obesity and Metabolism · 2020 · 34 citations · Full text

Pharmacy, Pharmacoeconomics, Pharmacotherapy +17

Extrapolated longer-term effects of the DAPA-CKD trial: a modelling analysis

Phil McEwan, Rebecca Boyce, Juan José García Sánchez et al. · Nephrology Dialysis Transplantation · 2022 · 29 citations · Full text

Pharmacy, Nephrology, Pharmacotherapy +14

Identification of undiagnosed atrial fibrillation using a machine learning risk prediction algorithm and diagnostic testing (PULsE-AI) in primary care: cost-effectiveness of a screening strategy evaluated in a randomized controlled trial in England

Nathan R. Hill, Lara Groves, Carissa Dickerson et al. · Journal of Medical Economics · 2022 · 26 citations · Full text

Pharmacy, Cardiology, Pharmacoeconomics +17

Cardiorenal disease in the United States: Future health care burden and potential impact of novel therapies

Phil McEwan, Angharad R. Morgan, Rebecca Boyce et al. · Journal of Managed Care & Specialty Pharmacy · 2022 · 15 citations · Full text

Pharmacy, Nephrology, Pharmacoeconomics +17